Click to Enlarge
Facebook
Twitter
Europe’s deepening vaccine “woes” make the Financial Times’s splash, after Brussels warned that supplies from pharmaceutical firm AstraZeneca would fall short in the first quarter. The paper says it comes on top of several EU countries suspending use of the jab over bloodclot fears and what the paper says are fading hopes that the US will provide extra doses.

Financial Times Front Page 24th of July 2024

Ministers may need to put Britain’s high-speed rail plans on hold as a result of significant cost overruns and delays, highlighting broader economic challenges and budgetary constraints, compounded by warnings about the NHS reaching a critical point and potential future reductions in transport capacity.

Read More »